Cargando…

Cognitive Functioning in Adults with Phenylketonuria in a Cohort of Spanish Patients

The early introduction of a low phenylalanine (Phe) diet has been demonstrated to be the most successful treatment in subjects with phenylketonuria (PKU), especially for preventing severe cognitive and neurological damages. However, it still concerns that even if treated in the first months of life...

Descripción completa

Detalles Bibliográficos
Autores principales: Luna, P. M., López-Paz, J. F., García, M., Amayra, I., Martínez, O., Pérez, M., Rodríguez, A. A., Pérez-Núñez, P., Ceberio, I., Mansilla, N., Soria, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931468/
https://www.ncbi.nlm.nih.gov/pubmed/36815863
http://dx.doi.org/10.1155/2023/9681740
_version_ 1784889256638939136
author Luna, P. M.
López-Paz, J. F.
García, M.
Amayra, I.
Martínez, O.
Pérez, M.
Rodríguez, A. A.
Pérez-Núñez, P.
Ceberio, I.
Mansilla, N.
Soria, C.
author_facet Luna, P. M.
López-Paz, J. F.
García, M.
Amayra, I.
Martínez, O.
Pérez, M.
Rodríguez, A. A.
Pérez-Núñez, P.
Ceberio, I.
Mansilla, N.
Soria, C.
author_sort Luna, P. M.
collection PubMed
description The early introduction of a low phenylalanine (Phe) diet has been demonstrated to be the most successful treatment in subjects with phenylketonuria (PKU), especially for preventing severe cognitive and neurological damages. However, it still concerns that even if treated in the first months of life with supplements and following a diet, they can show slight scores below people without PKU in neuropsychological assignments. We investigated 20 adults with classical PKU aged 19–48 years (mean age 29 years) and 20 heathy controls matched by age, gender, and years of education. Patients and controls were assessed with an extended neuropsychological battery, as well as psychological aspects and quality of life, also the last Phe level result was obtained. Results showed that the most affected cognitive domains are processing speed, executive functioning, memory, and also theory of mind, but very well-preserved verbal fluency, language, and visuospatial functioning. In quality of life, some significant results were seen specially in anxiety of Phe levels, anxiety of Phe levels during pregnancy, guilt if poor adherence to supplements, and if dietary protein restriction not followed. No significant results were obtained for the psychological variables. In conclusion, it has been shown that a combination of a low Phe diet, supplement intake, and keeping Phe levels in a low range seems appropriate to have the most normal and alike cognitive performance to persons without PKU.
format Online
Article
Text
id pubmed-9931468
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-99314682023-02-16 Cognitive Functioning in Adults with Phenylketonuria in a Cohort of Spanish Patients Luna, P. M. López-Paz, J. F. García, M. Amayra, I. Martínez, O. Pérez, M. Rodríguez, A. A. Pérez-Núñez, P. Ceberio, I. Mansilla, N. Soria, C. Behav Neurol Research Article The early introduction of a low phenylalanine (Phe) diet has been demonstrated to be the most successful treatment in subjects with phenylketonuria (PKU), especially for preventing severe cognitive and neurological damages. However, it still concerns that even if treated in the first months of life with supplements and following a diet, they can show slight scores below people without PKU in neuropsychological assignments. We investigated 20 adults with classical PKU aged 19–48 years (mean age 29 years) and 20 heathy controls matched by age, gender, and years of education. Patients and controls were assessed with an extended neuropsychological battery, as well as psychological aspects and quality of life, also the last Phe level result was obtained. Results showed that the most affected cognitive domains are processing speed, executive functioning, memory, and also theory of mind, but very well-preserved verbal fluency, language, and visuospatial functioning. In quality of life, some significant results were seen specially in anxiety of Phe levels, anxiety of Phe levels during pregnancy, guilt if poor adherence to supplements, and if dietary protein restriction not followed. No significant results were obtained for the psychological variables. In conclusion, it has been shown that a combination of a low Phe diet, supplement intake, and keeping Phe levels in a low range seems appropriate to have the most normal and alike cognitive performance to persons without PKU. Hindawi 2023-02-08 /pmc/articles/PMC9931468/ /pubmed/36815863 http://dx.doi.org/10.1155/2023/9681740 Text en Copyright © 2023 P. M. Luna et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Luna, P. M.
López-Paz, J. F.
García, M.
Amayra, I.
Martínez, O.
Pérez, M.
Rodríguez, A. A.
Pérez-Núñez, P.
Ceberio, I.
Mansilla, N.
Soria, C.
Cognitive Functioning in Adults with Phenylketonuria in a Cohort of Spanish Patients
title Cognitive Functioning in Adults with Phenylketonuria in a Cohort of Spanish Patients
title_full Cognitive Functioning in Adults with Phenylketonuria in a Cohort of Spanish Patients
title_fullStr Cognitive Functioning in Adults with Phenylketonuria in a Cohort of Spanish Patients
title_full_unstemmed Cognitive Functioning in Adults with Phenylketonuria in a Cohort of Spanish Patients
title_short Cognitive Functioning in Adults with Phenylketonuria in a Cohort of Spanish Patients
title_sort cognitive functioning in adults with phenylketonuria in a cohort of spanish patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931468/
https://www.ncbi.nlm.nih.gov/pubmed/36815863
http://dx.doi.org/10.1155/2023/9681740
work_keys_str_mv AT lunapm cognitivefunctioninginadultswithphenylketonuriainacohortofspanishpatients
AT lopezpazjf cognitivefunctioninginadultswithphenylketonuriainacohortofspanishpatients
AT garciam cognitivefunctioninginadultswithphenylketonuriainacohortofspanishpatients
AT amayrai cognitivefunctioninginadultswithphenylketonuriainacohortofspanishpatients
AT martinezo cognitivefunctioninginadultswithphenylketonuriainacohortofspanishpatients
AT perezm cognitivefunctioninginadultswithphenylketonuriainacohortofspanishpatients
AT rodriguezaa cognitivefunctioninginadultswithphenylketonuriainacohortofspanishpatients
AT pereznunezp cognitivefunctioninginadultswithphenylketonuriainacohortofspanishpatients
AT ceberioi cognitivefunctioninginadultswithphenylketonuriainacohortofspanishpatients
AT mansillan cognitivefunctioninginadultswithphenylketonuriainacohortofspanishpatients
AT soriac cognitivefunctioninginadultswithphenylketonuriainacohortofspanishpatients